Incidence, Pathogenesis, and Management of Proton Pump Inhibitor-Induced Nephrotoxicity | SpringerLink
Protonix Kidney Disease Lawsuit Lawyers | John Foy & Associates
CHRONIC KIDNEY DISEASE WITH NEUROGLYCOPENIA | PPT
Possible protective effect of pantoprazole against cisplatin-induced nephrotoxicity in head and neck cancer patients: a randomized controlled trial | SpringerLink
Appropriate Use and Safety Concerns of Proton Pump Inhibitors
Proton pump inhibitors associated acute kidney injury and chronic kidney disease: data mining of US FDA adverse event reporting system | Scientific Reports
JCM | Free Full-Text | Impact of Acid Suppression Therapy on Renal and Survival Outcomes in Patients with Chronic Kidney Disease: A Taiwanese Nationwide Cohort Study
Protonix Lawsuits: Spotlight on the Rising Legal Challenges
Doc, I heard on the news that this heartburn medicine is bad for my kidneys. What should I do?” – AJKD Blog
Could Your Heartburn Medication Be Causing Kidney Disease, Dementia and More? - Philadelphia Magazine
Joye Law Firm - Kidney Disease Injury Claims
Protonix | Chicago Product Liability Lawyers Moll Law Group
Proton pump inhibitors and increased reporting odds of renal neoplasms: FAERS-based adverse event data mining and analysis
Doc, I heard on the news that this heartburn medicine is bad for my kidneys. What should I do?” – AJKD Blog
Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis | Scientific Reports
Proton pump inhibitors associated acute kidney injury and chronic kidney disease: data mining of US FDA adverse event reporting system | Scientific Reports
PDF) Proton pump inhibitors associated acute kidney injury and chronic kidney disease: data mining of US FDA adverse event reporting system
Doc, I heard on the news that this heartburn medicine is bad for my kidneys. What should I do?” – AJKD Blog
Pantoprazole‑induced acute kidney injury: A case report
Proton pump inhibitors use and risk of chronic kidney disease: Evidence-based meta-analysis of observational studies - Clinical Epidemiology and Global Health
Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis | Scientific Reports